Editing 2C-E (section)

{{cs1 config|name-list-style=vanc|display-authors=6}}
{{Infobox drug
| Verifiedfields = verified
| Watchedfields = verified
| verifiedrevid = 477216166
| drug_name = 
| image = 2C-E.svg
| width = 
| caption = 
| image2 = 2C-E-3d-sticks.png
| width2 = 
| caption2 = 

<!-- Clinical data -->
| pronounce = 
| tradename = 
| Drugs.com = 
| MedlinePlus = 
| licence_CA = 
| licence_EU = 
| DailyMedID = 
| licence_US = 
| pregnancy_AU = 
| pregnancy_category = 
| dependency_liability = 
| addiction_liability = 
| routes_of_administration = [[Oral administration|Oral]]
| class = [[Serotonin]] [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[agonist]]; [[Serotonergic psychedelic]]; [[Hallucinogen]]
| ATC_prefix = None
| ATC_suffix = 

<!-- Legal status -->
| legal_BR = F2
| legal_CA = Schedule III
| legal_DE = Anlage I
| legal_NZ = Class C
| legal_UK = Class A
| legal_US = Schedule I
| legal_status = 

<!-- Pharmacokinetic data -->
| bioavailability = 
| protein_bound = 
| metabolism = 
| metabolites = 
| onset = 
| elimination_half-life = 
| duration_of_action = 
| excretion = 

<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 71539-34-9
| CAS_supplemental = 
| PubChem = 24729233
| PubChemSubstance = 
| IUPHAR_ligand = 
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 21106222
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = I190284UXX
| KEGG = 
| ChEBI = 
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 124063
| NIAID_ChemDB = 
| PDB_ligand = 
| synonyms = 2,5-Dimethoxy-4-ethylphenethylamine; 4-Ethyl-2,5-dimethoxyphenethylamine; Aquarust

<!-- Chemical data -->
| IUPAC_name = 2-(4-ethyl-2,5-dimethoxyphenyl)ethan-1-amine
| C=12 | H=19 | N=1 | O=2 
| SMILES = COc1cc(CC)c(cc1CCN)OC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C12H19NO2/c1-4-9-7-12(15-3)10(5-6-13)8-11(9)14-2/h7-8H,4-6,13H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = VDRGNAMREYBIHA-UHFFFAOYSA-N

<!-- Physical data -->
| solubility = >70
}}

'''2C-E''' is a [[Psychedelic drug|psychedelic]] [[phenethylamines|phenethylamine]] of the [[2C (psychedelics)|2C family]]. It was first synthesized by [[Alexander Shulgin]]<ref name="PiHKAL">{{CitePiHKAL}} [https://www.erowid.org/library/books_online/pihkal/pihkal024.shtml 2C-E in ''PiHKAL'']</ref> and documented in his book ''[[PiHKAL]]''. Like the other substances in its family, it produces sensory and cognitive effects in its physical reactions with living organisms.<ref>{{cite journal | vauthors = Papaseit E, Olesti E, Pérez-Mañá C, Torrens M, Grifell M, Ventura M, Pozo OJ, de Sousa Fernandes Perna EB, Ramaekers JG, de la Torre R, Farré M | title = Acute Effects of 2C-E in Humans: An Observational Study | journal = Frontiers in Pharmacology | volume = 11 | pages = 233 | date = 2020 | pmid = 32256350 | pmc = 7093582 | doi = 10.3389/fphar.2020.00233 | doi-access = free }}</ref>